Background: Pediatric migraine prophylaxis is indicated when headaches are frequent and/or disabling. We aimed to conduct a study to compare the efficacy of cinnarizine and amitriptyline in pediatric migraine prophylaxis.
Methods: In a randomized, double-blind trial, patients aged 4-17 years with migraine who were eligible for prophylaxis enrolled.
Purpose Of Review: Headache disorders in children and adolescents are common. Among the different headache disorders, migraine and tension headache are highly prevalent and often debilitating. Pharmacological treatments for pediatric patients are often not approved or effective.
View Article and Find Full Text PDF